Moreover, Kim et al. demonstrated that the pattern of serum CEA clearance after radical tumor resection in rectal cancer patients could be used as a surrogate marker for predicting cancer-specific mortality [22]. The gene discussed is CEACAM5; the disease is rectal cancer.